Cosmic,
Where are they with the FDA? Let's assume the FDA wants to force stem cell technology fully down the drug development path, are they back at square one having to justify safety in animal studies?? Especially in the midst if apparently refining the extraction technology? It seems logical that this could be where they are at rendering involvement from Andrews, Inventiv, Hill and all these INDs all null and void until they get a protocol acceptable from a safety standpoint to the FDA..
If they potentially got fast track for something like ALS, what does that bypass?
They could move much faster internationally, but clearly must wait for the patent. Which why the heck is the EU patent taking so long? Maybe that won't happen either...
They seriously need to think about corporate structure including leadership. This damn thing does not have to be stagnant on all fronts. Just making the technology and people mentioned alongside look that much more clueless..